Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

BG 00012

Known as: 00012, BG, BG-00012, BG00012 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Objective: To evaluate the mechanism of action of dimethylfumarate (DMF), a novel oral therapeutic for the treatment of multiple… Expand
Highly Cited
2011
Highly Cited
2011
Inflammation and oxidative stress are thought to promote tissue damage in multiple sclerosis. Thus, novel therapeutics enhancing… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Review
2010
Review
2010
Importance of the field: One of the disadvantages of currently available disease-modifying drugs (DMDs) for multiple sclerosis… Expand
2010
2010
Disease-modifying therapies (DMTs) for treating multiple sclerosis (MS) are entering a period of rapid and profound change that… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Highly Cited
2008
Highly Cited
2008
BACKGROUND Oral fumarate (BG00012) might have dual anti-inflammatory and neuroprotective effects. Our aim was to assess the… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2